HCA Healthcare, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $75.6B | $70.6B | $65.0B | $60.2B | $58.8B |
| Interest expense | $2.2B | $2.1B | $1.9B | $1.7B | $1.6B |
| Pretax income | $9.8B | $8.5B | $7.7B | $8.6B | $9.8B |
| Income tax expense | $2.0B | $1.9B | $1.6B | $1.7B | $2.1B |
| Net income | $6.8B | $5.8B | $5.2B | $5.6B | $7.0B |
| Balance Sheet | |||||
| Cash and equivalents | $1.0B | $1.9B | $935.0M | $908.0M | $1.5B |
| Current assets | $15.8B | $16.4B | $14.9B | $13.6B | $13.5B |
| Total assets | $60.7B | $59.5B | $56.2B | $52.4B | $50.7B |
| Current liabilities | $16.4B | $15.2B | $12.7B | $9.9B | $9.6B |
| Total debt | $46.5B | $43.0B | $39.9B | $38.4B | $34.8B |
| Stockholders' equity | -$6.0B | -$2.5B | -$1.8B | -$2.8B | -$933.0M |
| Cash Flow Statement | |||||
| Cash from operations | $12.6B | $10.5B | $9.4B | $8.5B | $9.0B |
| Depreciation and amortization | $3.5B | $3.3B | $3.1B | $3.0B | $2.9B |
| Stock-based compensation | $401.0M | $360.0M | $262.0M | $341.0M | $440.0M |
| Capital expenditure | $4.9B | $4.9B | $4.7B | $4.4B | $3.6B |
| Free cash flow | $7.7B | $5.6B | $4.7B | $4.1B | $5.4B |
| Dividends paid | $679.0M | $690.0M | $661.0M | $653.0M | $624.0M |
| Share repurchases | $10.1B | $6.0B | $3.8B | $7.0B | $8.2B |
| Impairments | $0 | $0 | $0 | $0 | $0 |
Shares outstanding 221.8M
Annual filing data through FY ended December 31, 2025; float as of July 11, 2026.
Recent filings
- July 14, 2026 8-K
- June 18, 2026 8-K
- April 30, 2026 8-K
- April 29, 2026 10-Q
- April 28, 2026 8-K
- April 27, 2026 8-K
- April 24, 2026 8-K
- February 25, 2026 8-K